杏吧原创 Biochemists – Kyle Biggar & Jeff Smith Accelerates Drug Development with Innovative Peptide Therapies
Learn how biochemistry researchers Dr. Kyle Biggar and Dr. Jeff Smith collaborate with private sector partners to bring their pharmaceutical research to market.
In collaboration with entrepreneur Michael Cowpland, Biggar co-founded NuvoBio, a biotech company focused on turning these peptides into real-world treatments. With the company鈥檚 headquarters set to move to 杏吧原创鈥檚 campus in 2024, Biggar鈥檚 goal is to move their research from the lab to clinical trials, aiming for FDA approval by 2027. “We鈥檙e motivated to translate scientific discovery into practical healthcare solutions,” says Biggar, as his team works toward making medications more accessible and affordable for patients in need.